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Summary 
Human milk is one of the richest biological fluids. It is considered to be the gold standard of 
infant nutrition providing essential nutrients for optimal growth and development. Besides 
nutrition, breast milk helps protect the immunologically immature newborn from enteric 
infections, the development of allergy, or inflammation of the gastrointestinal tract. This 
protection is mediated by a variety of soluble and cellular factors in breast milk such as secretory 
immunoglobulin A, lysozyme, lactoferrin and oligosaccharides. In human milk, oligosaccharides 
are the third largest component besides lactose and fat. Their structural diversity is high and 
unique since other mammalian milk oligosaccharides are less complex. The main function of 
milk oligosaccharides is the prevention of pathogen attachment to epithelial cell surface 
carbohydrates by acting as soluble surface receptors. However the exact role of milk 
oligosaccharide on immune development, tolerance and regulation of inflammation is not fully 
understood. 
In this thesis I studied the function of specific milk oligosaccharides, the sialyllactoses, on 
mucosal immunity. The complexity of mouse milk oligosaccharides is low as it only contains 
lactose and two forms of sialyllactose, namely 3SL and 6SL. To investigate sialyllactose 
function, we used α2,3- and α2,6 sialyltransferase-null mice that lack either 3SL or 6SL. Cross-
fostering experiments between C57Bl/6 and sialyltransferase-null mice were setup to feed mice 
with normal or sialyllactose-deficient milk. Neither the exposure to normal, nor to sialyllactose-
deficient milk had an effect on the development of mucosal leukocyte populations. However, 
when adult mice were challenged by dextran sulfate sodium (DSS) in drinking water, mice 
previously exposed to 3SL-deficient milk were more resistant to colitis than mice exposed to 
normal or 6SL-deficient milk. The analysis of intestinal microbiota revealed a different 
colonization pattern depending on the presence or absence of 3SL. A Ruminococcaceae 
species was enriched in the intestine of mice exposed to 3SL during lactation. We correlated the 
composition of the intestinal microbiota to the severity of DSS-induced colitis by colonizing 
germfree mice with microbiota from mice fed with normal or 3SL-deficient milk. As anticipated, 
mice colonized with microbiota derived from mice exposed to 3SL-deficient milk were less 
susceptible to DSS-induced colitis than mice colonized with normal microbiota. 
In conclusion, we demonstrate that the exposure to a single milk oligosaccharide exerts long 
term effects on intestinal bacterial colonization, as shown by Ruminococcaceae specie 
enrichment. Furthermore we show that the bacterial colonization affects the susceptibility of the 
host to DSS-induced colitis. In this study we provide evidence that Ruminococcaceae are pro-
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inflammatory bacteria that are specifically enriched through 3SL exposure. To examine the exact 
contribution of Ruminococcaceae in the development of DSS-induced colitis further experiments 
are required in particular the specific enrichment of Ruminococcaceae in culture.  
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Zusammenfassung 
Muttermilch ist eines der reichhaltigsten biologischen Sekrete überhaupt. Sie ist das „non plus 
ultra“ in der Säuglingsernährung, da sie essentielle Nährstoffe für eine optimale Entwicklung des 
Säuglings liefert. Neben dem Ernähren des Säuglings schützt die Muttermilch den 
immunologisch unreifen Säugling vor Infektionen, der Entwicklung von Allergien oder 
Entzündungen im Gastrointestinaltrakt. Dieser Schutz wird durch eine Reihe von löslichen und 
zellulären Faktoren in der Muttermilch vermittelt. Diese beinhalten sekretorisches Immunglobulin 
A, Lysozym, Lactoferrin und Oligosaccharide. Die Oligosaccharide sind neben Fett und Laktose 
die drittgrösste Komponente in der Humanmilch. Ihre hohe Strukturdiversität ist einzigartig in der 
Säugetiermilch. Die Oligosaccharide in der Muttermilch verhindern das Anheften von 
Pathogenen an die Epithelzellen der Darmmukosa, indem sie als lösliche Rezeptoranaloge 
fungieren. Ihr Rolle in der Entwicklung des Immunsystems, der Toleranz und der Regulation von 
Entzündungprozessen ist jedoch unbekannt. 
Während meiner Doktorarbeit untersuchten wir die Funktion von spezifischen Milch-
Oligosacchariden, den Sialyllaktosen, im mukosalen Immunsystem. Die Oligosaccharide in der 
Mausmilch, Laktose und die zwei Formen von Sialyllaktose (3SL und 6SL), weisen nur eine 
geringe Komplexität auf. Um die Funktion der Sialyllaktose zu untersuchen, verwendeten wir 
α2,3- und α2,6 Sialyltransferase-defiziente Mäuse, die keine 3SL oder 6SL aufweisen. In 
sogenanten Fremdpflege-Experimenten zwischen C57Bl/6 und Sialyltransferase-defizienten 
Mäusen, wurden die Mäuse mit normaler oder Sialyllaktose-defizienter Milch gefüttert. Weder 
die Fütterung von normaler noch Sialyllaktose-defizienter Milch hatte eine Auswirkung auf die 
Entwicklung der Leukozytenpopulationen in der Mukosa. Allerdings zeigten adulte Mäuse, die in 
Präsenz von 3SL-defizienter Milch aufwuchsen eine höhere Resistenz gegenüber einer Dextran 
Sulfat Sodium (DSS)-induzierten Kolitis im Vergleich zu Mäusen, die mit normaler oder 6SL-
defizienter Milch gefüttert wurden. Die Analyse der intestinalen Mikrobiota zeigte ein 
unterschiedliches Kolonisierungsmuster, abhängig von der Präsenz oder Absenz von 3SL. Die 
Prägung durch 3SL während der Laktation hatte eine Anreicherung von Ruminococcaceae 
Spezies im Kolon zur Folge. Durch die Kolonisierung keimfreier Mäuse mit der Mikrobiota von 
Mäusen, die mit normaler oder 3SL-defizienter Milch gefüttert wurden, konnten wir eine 
Korrelation zwischen der Zusammensetzung der intestinalen Mikrobiota und der Empfindlichkeit 
für DSS-induzierte Kolitis feststellen. Mäuse, die die Mikrobiota der mit 3SL-defizienter Milch 
gefütterten Tiere erhielten, waren weniger empfindlich für DSS-induzierte Kolitis als 
Kontrollmäuse. 
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Zusammenfassend zeigen wir anhand der erhöhten Ansammlung von Ruminococcaceae 
Spezies, dass die Prägung durch ein einzelnes Milch-Oligosaccharid langzeitig die 
Kolonisierung des Kolons beeinflussen kann. Des Weiteren konnten wir zeigen, dass die 
bakterielle Zusammensetzung die Empfindlichkeit der Mäuse für DSS-induzierte Kolitis 
beeinflusst. Wir geben in dieser Doktorarbeit Hinweise dafür, dass Ruminococcaceae Spezies 
eine entzündungsfördernde Wirkung aufweisen können und ihre Anreicherung im Kolon 
spezifisch auf der Exposition von 3SL basiert. Um den genauen Beitrag der Ruminococcaceae 
Spezies in der Entwicklung von DSS-induzierter Kolitis zu untersuchen, sind jedoch weitere 
Experimente erforderlich. Dies beeinhaltet insbesondere die Anreicherung der 
Ruminococcoaceae Spezies in Kultur. 
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Abbreviations 
3SL  sialyl(α2,3)lactose 
6SL  sialyl(α2,6)lactose 
CD  Cluster of differentiation 
CF  Cross-fostering 
DSS  Dextran sulfate sodium 
Fuc  Fucose 
Gal  Galactose 
GALT  Gut associated lymphoid tissue 
Gb3  Globotriaosylceramide 
GIT   Gastrointestinal tract 
Glc  Glucose 
GlcNAc N-acetylglucosamine 
GM1/3  Mono/tri-sialotetrahexosylganglioside 
HPAEC High performance anion exchange chromatography 
IBD  Inflammatory bowel disease 
IgA  Immunoglobulin A 
IL  Interleukine 
IRAK  Interleukin 1 receptor-associated kinase 
IRF3  Interferon-regulatory factor 3 
Iκκ   IκB kinase 
M cell  Microfold cell 
MyD88  Myeloid differentiation primary response gene (88) 
NALT  Nasopharynx associated lymphoid tissue 
Neu5Ac N-acetylneuraminic acid 
Neu5Gc N-glycolylneuraminic acid 
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NF-kB  nuclear factor kappa-light-chain-enhancer of activated B cells 
NOD   nucleotide-binding oligomerization domain 
PPARγ Peroxisome proliferator-activated receptor gamma 
RT  Reverse transcription 
Sia  Sialic acid 
SIGGR Single immunoglobulin IL-1R-related molecule 
SL  Sialyllactose 
T reg  T regulatory cell 
TGF-β  Transforming Growth Factor beta 
Th1  T helper 1 
Th2  T helper 2 
TIRAP  toll-interleukin 1 receptor domain containing adaptor protein;  
TLR  Toll like receptor 
TNF-α  Tumor necrosis factor alfa 
TOLLIP Toll interacting protein 
TTGE  temporal temperature gradient gel electrophoresis 
Wt  Wild type 
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Human milk 
Human milk is considered to be the „gold standard“ in infant nutrition by providing optimal 
nutrients for normal growth and development. These nutrients include macromolecules such as 
carbohydrates, lipids and proteins and micronutrients such as vitamins and minerals (Newton, 
2004). Apart from nutritional benefits, human milk contains multiple bioactive and 
immunomodulatory components. They provide active and passive immunity in the early months 
and years of life when the neonate’s immune system starts to fully develop (Lönnerdal, 2010). 
The importance of human milk is illustrated in developing countries where breastfeeding has 
shown protective effects on mortality rate. Not only were death rates decreased, but 
improvements of cognitive and psychosocial development were also documented (Anderson et 
al., 1999; Labbok et al., 2004). 
 
Bioactive molecules in milk 
Components of the adaptive immune system 
The most recognized protection from mother to the child is transplacental passage of 
immunoglobulins during pregnancy followed by secretory immunoglobulin A (IgA) (Hugot et al.) 
in milk during lactation (Hanson, 1961). IgA is produced by plasma cells in the mammary gland 
that originate from primed B cells from the small intestine or the bronchial tree (Halsey et al., 
1983). Receptor mediated transport of dimeric IgA through the mammary epithelial cell results in 
secretion in milk (Hanson, 1998). Through breastfeeding IgA enters the gastrointestinal tract 
without being digested, binds to enteric pathogens and thus inhibits their attachment to the 
epithelial layer. The inability of the neonate to produce IgA in the first few weeks of life, is thus 
compensated (Hanson et al., 1991) (Fig. 1 and 2). 
In addition to antibody mediated immunity, cellular immunity is transferred from mother to child. 
Depending on the stage of lactation, multiple leukocyte types are present in milk (Goldman, 
1993). The most common are macrophages and neutrophils. Lymphocytes, mostly T cells, are 
also present. Macrophages for example express activation markers and are suggested to 
influence lymphocyte function in infants by releasing immunmodulatory cytokines. Additionally 
they contain engulfed IgA, which is most likely released on contact with bacteria in the gut 
inhibiting microbial attachment to the epithelial layer (Brandtzaeg, 2003). Activated T cells in milk 
are hypothesized to compensate for the immature function of neonatal T cells and assist their 
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Heavily glycosylated milk mucins or lactadherin inhibit binding of certain pathogens to epithelial 
cells (Schroten et al., 1992). Small lipids such as free fatty acids and monoglycerides are 
produced by enzymatic digestion of triglycerides in human milk. They protect the neonate from 
viral infections by destroying enveloped viruses (Isaacs, 2001). Finally, hormones and growth 
factors are additional bioactive molecules found in milk that modulate the gastrointestinal tract 
and are to a certain extent also absorbed into systemic circulation (Goldman, 2000) (Fig. 2). 
 
Immunomodulatory agents 
Human milk contains a great number of cytokines. These cytokines impact humoral and cellular 
immunity, macrophage activity and pro- or anti-inflammatory effects (Goldman, 1993). The main 
source of cytokines is the mammary gland itself, although small amounts are also directly 
produced from leukocytes in milk. Two anti-inflammatory cytokines that are present in human 
milk are IL-10 and TGF-β (Goldman et al. 1982). IL-10 dampens Th1 response by inhibition of 
pro-inflammatory cytokine release (Garofalo et al., 1995). TGF-β is implicated in immune 
regulation by down-regulating inflammation and improving healing of damaged intestinal cells 
(Field, 2005; Saito et al., 1993). Pro-inflammatory cytokines such as IL-1β, IL-6, IL-8 and TNFα 
are also found in milk. However, their activity is reduced by the presence of cognate soluble 
receptors or receptor antagonists (Field, 2005; Hawkes et al., 2002). Moreover, the higher 
concentration of the anti-inflammatory cytokine IL-10 in milk suggests an overall anti-
inflammatory condition mediated by milk components. Several questions about the physiological 
role of cytokines in milk remain unanswered. For example it is unclear how cytokines survive 
transit through the gastrointestinal tract. Other immunomodulatory agents such as a soluble form 
of Toll-like receptor (TLR) 2 and soluble CD14 might sensitize the innate immune system during 
bacterial colonization (Labeta et al., 2000; LeBouder et al., 2003). TLR2 is activated by Gram-
positive bacteria. The soluble form found in milk might prevent extensive activation upon 
bacterial recognition during colonization and thus prevent diseases such as necrotizing 
enterocolitis (LeBouder et al., 2006). CD14 plays a pivotal role in recognition of microbial cell 
wall components of both Gram-positive and Gram-negative bacteria. The high concentration of 
CD14 in milk indicates its role in regulating immune responses of neonates during bacterial 
colonization (Labeta et al., 2000) (Fig. 2). 
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Bioactive molecules in milk
Components of the 
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Milk oligosaccharides 
Human milk oligosaccharides are the third largest solute besides lactose and fat. By definition, 
oligosaccharides are free carbohydrates comprised of between three to ten monosaccharides 
covalently linked by a glycosidic bond (Kunz et al., 2000). Milk oligosaccharides are indigestible 
by the infant gut and therefore are not used as nutrients (Engfer et al., 2000; Gnoth et al., 2000). 
Milk oligosaccharides were initially believed to be accidental functionless by-products of active 
glycosyltransferases in the mammary gland during lactation (Newburg et al., 2005). However the 
structural homology of free oligosaccharides to epithelial cell surface glycans suggested they are 
functionally active. Indeed, one of their main functions lies in their ability to serve as receptor 
homologues of cell surface receptors, thereby inhibiting bacterial attachment to the cell surface 
(Kunz et al., 2000) (Fig. 2). 
 
 
 
 
 
 
 
 
 
 
Figure 2: Bioactive molecules in milk.  
Bioactive molecules in milk can be divided into four functional groups: components of the adaptive 
immune system, multifunctional milk components, immunomodulatory agents, milk oligosaccharides.  
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Milk oligosaccharide structure 
One liter of human milk contains 5-10 g of oligosaccharides placing this fraction within the three 
largest components of human milk along with proteins and lipids (Kunz Rudloff 2002). The 
composition and variability of milk oligosaccharides is mediated by a set of glycosyltransferase 
enzymes, whose expressions are regulated in the mammary gland. The sugar monomers 
include glucose (Glc), galactose (Gal), N-acetylglucosamine (GlcNAc), fucose (Fuc), and sialic 
acid (Sia). Most milk oligosaccharides have the disaccharide lactose (Galβ1,4Glc) at their 
reducing end. Elongation at the non-reducing end is performed by an enzymatic transfer of 
sugar monomers. Characteristic elongations contain repetitive units of the disaccharide N-
acetyllactosamine (Galβ1,3/4GlcNAc). The lactose or N-acetyllactosamine backbones are 
further modified by α2,3-, α2,6 sialylation or α1,2-, α1,3-, or α1,4 fucosylation. The modification 
of lactose by either sialic acid or fucose form the smallest oligosaccharide fraction such as 
2’fucosyllatose or 3’fucosyllatose and 3’sialyllactose or 6’sialyllactose respectively (Kunz et al., 
2000) (Fig. 3). 
 
Milk oligosaccharides are divided into neutral and acidic oligosaccharides, depending on the 
absence or presence of sialic acid (Gopal and Gill, 2000). Approximately 200 different structures 
of neutral and acidic oligosaccharide have been detected to date (Mehra and Kelly, 2006). The 
concentration and structure of milk oligosaccharides between individuals depends on the 
secretor status, the ABO blood group type and the Lewis blood group type (Newburg, 2000; 
Viverge et al., 1990). The called “nonsecretor” mothers lack active copies of the gene coding for 
fucosyltransferase FucT-II and therefore cannot synthesize fucose(alpha)1,2 epitopes such as 
2’fucosyllactose. The prevalence of nonsecretor mothers in Europe is approximately 20% 
(Viverge et al., 1990). Another fucosyltransferase termed FucT-III which is the only 
fucosyltranferase that attaches fucose to N-acetylglucosamine in an α1,4 linkage is found in 
“Lewis-positive” but not “Lewis-negative” individuals. Thus milk oligosaccharides depend on 
Lewis blood group and secretor status and are therefore different in their structures (Thurl et al., 
1997). 
 
The concentration of milk oligosaccharides varies strongly during lactation (Miller et al., 1994). 
High concentrations of oligosaccharides are detected during early lactation with levels 5-10 
times lower towards weaning (Mehra and Kelly, 2006). Human milk is very unique in the high 
content and complexity of milk oligosaccharides, especially when compared to domestic 
mammals such as cows, sheep, goats and horses (Urashima et al., 1997). A pronounced 
Introduct
 
differenc
contains
linked to
α1,3Gal
the acid
acetylne
milk only
gene co
Neu5Ac
Urashim
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3
Milk olig
trisaccha
from Bod
ion 
e is seen 
 only few o
 Gal or G
 or α1,3Ga
ic fraction o
uraminic a
 Neu5Ac e
ding for CM
 to CMP-N
a et al., 200
. Structural 
osaccharides
rides, e.g.,s
e, 2009). 
in the neu
ligosaccha
lcNAc. Mo
lNAc at the
f non-huma
cid (Neu5A
xists. The 
P-Neu5Ac 
euGc (Boe
1). 
compostitio
 are classif
ialyllactose o
tral fractio
rides that a
reover, un
 non-reduc
n milk olig
c) and N-g
loss of Neu
hydroxylas
hm and S
n of milk ol
ied as neut
r fucosyllac
n of non-h
re fucosyla
iquely foun
ing terminu
osaccharide
lycolylneur
5Gc in hum
e, an enzym
tahl, 2007
igosacchar
ral and acid
tose, or com
 
uman milk 
ted and is
d in non-h
s (Urashim
s two distin
aminic acid
ans is cau
e that con
; Brinkman
ides.  
ic oligosacc
plex high-m
oligosacch
 dominated
uman milk
a et al., 20
ct forms of
 (Neu5Gc
sed by a m
verts the su
-Van der 
harides. Th
olecular-we
arides. Th
 by oligosa
 are attach
01). Furthe
 sialic acid 
) whereas 
utation in t
gar nucleo
Linden et 
ey contain 
ight glycans
17
is fraction 
ccharides 
ments of 
rmore, in 
exists, N-
in human 
he human 
tide CMP-
al., 2000; 
short-chain 
. (Modified 
Introduction 
18 
 
Prebiotics
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Biological effects of human milk oligosaccharides 
Prebiotics 
The definition of a prebiotic is a non-digestible food ingredient that beneficially affects the host 
by selectively stimulating the growth and/or activity of a limited number of bacteria in the colon, 
and thus improves host health (Gibson and Roberfroid, 1995). Human milk oligosaccharides in 
breast milk are considered prebiotics. Most are indigestible due to lack of luminal enzymes able 
to cleave most glycosidic linkages in the gastrointestinal tract (Engfer et al., 2000; Gnoth et al., 
2000). However, bacteria in the colon express glycosidases and metabolize human milk 
oligosaccharides (Hill, 1995; Sela and Mills, 2010). Studies have shown that initial feeding with 
milk oligosaccharides changes the microbiota towards a predominant population of gram-
positive nonsporulating bacilli, Bifidobacteria, and lactic acid-producing organisms (Lactobacilli).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Potential effects of prebiotics.  
Prebiotics are best known for selectively increasing the probiotic bacteria bifidobacteria and lactobacilli. 
These probiotic bacteria influence fecal texture and fecal output. Furthermore, they modulate immune 
responses by for example increasing IgA production (see probiotic section). The fermentation products of 
the probiotic bacteria such as short-chain fatty acids and lactic acids further improve host’s health by 
delivering energy and by creating a hostile environment for potential pathogens by acidification and a 
decreased pH. (modified from (Sherman et al., 2009). 
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Non-breastfed infants show an adult-type microbiota with predominance of Enterobacteriaceae, 
Clostridium, and Bacteroides (Harmsen et al., 2000). Health promoting effects of prebiotics are 
indirectly mediated through the resident Bifidobacteria that produce short-chain fatty acids and 
lactic acid by fermentation, thus creating an acidic milieu. This milieu increases the absorption of 
calcium and magnesium and creates a hostile environment for potential pathogens (Abrams et 
al., 2005; Sherman et al., 2009). Potential effects of prebiotics are summarized in Fig. 4 
(Sherman et al., 2009). 
 
Anti-adhesive effects 
Adhesion to the epithelial cell surface is the first step of a bacterial infection. Therefore virulence 
of many pathogens depends on their ability to bind to a host epithelial surface. This adhesion is 
often mediated by bacterial lectins, glycan-binding proteins. Structural homology between milk 
oligosaccharides and cell surface glycans suggests that milk oligosaccharides are used as 
soluble decoys that prevent pathogen adhesion and thereby infection (Newburg et al., 2005; 
Sharon, 1996). This was illustrated by the binding of Campylobacter jejuni, one of the major 
causes of diarrhea worldwide, to soluble 2’-fucosyllactose (Cravioto et al., 1990). Fucosylated 
milk oligosaccharides vary among mothers due to genetic polymorphisms of the responsible 
fucosyltransferases. The incidence of Campylobacter induced diarrhea was shown to be 
inversely related to the amount of soluble 2’-fucosyllactose present in mother’s milk (Morrow et 
al., 2004). Ex vivo experiments confirmed an inhibitory effect of fucosylated milk 
oligosaccharides on the attachment of Campylobacter to the intestinal mucosa (Ruiz-Palacios et 
al., 2003). Table 1 shows additional identified milk oligosaccharide species that inhibit 
pathogenesis of bacterial and viral infections. 
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Table 1: Pathogen inhibition through human milk glycans (modified from (Newburg, 2009)) 
A great number of human milk glycans were identified to inhibit pathogens. These glycans include free 
oligosaccharides (fucosylated and sialylated), mucins (O-glycosidic-linked high-molecular-mass 
glycoproteins in the membranes surrounding milk fat globules), glycosaminoglycans such as chondroitin 
sulfate (long unbranched polysaccharides consisting of a repeating disaccharide unit) and 
glycoshingolipids (sulfatide, Gb3: Globotriaosylceramide; GM1/3: mono/tri-sialotetrahexosylganglioside). 
 
 
Glycan  Pathogen Reference 
Oligosaccharide 
fractions 
Streptococcus pneumonia 
Enteropathogenic Escherichia coli 
Listeria monocytogenes 
(Andersson et al., 1986) 
(Cravioto et al., 1990)  
(Coppa et al., 2003) 
Fucosylated 
oligosaccharides 
 
Campylobacter jejuni 
Vibrio cholerae 
Escherichia coli Stable toxin 
(Ruiz-Palacios et al., 2003) 
(Ruiz-Palacios et al., 2003) 
(Newburg, 1999) 
Sialyllactose 
 
Cholera toxin 
Enteropathogenic Escherichia coli 
P. aeruginosa 
Aspergillus fumigatus conidia 
Influenza virus 
Polyomavirus 
Helicobacter pylori 
(Idota et al., 1995) 
(Stins et al., 1994; Virkola et al., 1993) 
(Devaraj et al., 1994)  
(Bouchara et al., 1997) 
(Gambaryan et al., 1997; Matrosovich et al., 1993) 
(Stehle et al., 1994) 
(Mysore et al., 1998) 
Mucin S-fimbriated E. coli (Schroten et al., 1992) 
Chondroitin sulfate HIV (Newburg et al., 1995) 
Sulfatide HIV (Viveros-Rogel et al., 2004) 
Gb3 Shiga toxin (Newburg et al., 1992) 
GM1 Labile toxin, cholera toxin (Otnaess et al., 1983) 
GM3 Enteropathogenic Escherichia coli (Idota and Kawakami, 1995) 
 
 
Impact on intestinal epithelial cells 
Milk oligosaccharides have been shown to exhibit direct effects on glycosylation patterns of 
epithelial cell surface glycans. An in vitro study using Caco-2 cells treated with 3’sialyllactose 
(3SL) showed reduced cell surface expression of α2,3 and α2,6 linked sialic acid residues 
(Angeloni et al., 2005). This glycome-modifying effect reduced binding of enteropahtogenic 
Escherichia coli by 50%. The cause of reduced sialic acid residues was found to be a lower 
expression level of certain sialyltransferases. Therefore exogenous glycans can regulate gene 
expression in the host by a yet unknown mechanism (Angeloni et al., 2005). Milk 
oligosaccharides have been also shown to exhibit effects on growth, differentiation and 
apoptosis (Kuntz Sabine et al., 2008). In vitro stimulation of intestinal epithelial cell lines with 
milk oligosaccharides fractions induced growth inhibition by modulating epidermal growth factor 
signaling and gene expression of cell cycle regulators (Kuntz et al., 2009). This observation 
stands in contrast to the increased cell proliferation when total milk was analyzed on intestinal 
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cells (Ichiba et al., 1992), suggesting a possible control mechanism of intestinal cell growth by 
both milk oligosaccharides and total milk.  
 
Systemic effects 
A small amount of indigested milk oligosaccharides are absorbed by the infant’s intestine by 
crossing epithelial layer via receptor-mediated transcytosi or paracellular transport (Gnoth et al., 
2001). Detection of milk oligosaccharides in urine of breastfed, but not formula-fed infants 
suggests their existence in the systemic circulation (Obermeier et al., 1999; Rudloff et al., 1996). 
The appearance of milk oligosaccharides in circulation may alter certain protein-carbohydrate 
interactions. Putative carbohydrate binding partners of milk oligosaccharides include galectins, 
siglecs and selectins. The galectins recognize βGal-containing oligosacchiardes such as poly-N-
acetyllactosamines found in the backbone structures of milk oligosaccharides. Galectins were 
shown to mediate cell adhesion, cell growth and regulate apoptosis (Perillo et al., 1998). The 
siglecs, sialic-acid-binding immunoglobulin-like lectins, recognize sialylated glycans and are 
involved in biological processes such as immune cell signaling (Varki and Angata, 2006). 
Selectins bind to specific fucosylated and sialylated oligosaccharides on their glycan ligands 
(Varki, 1994; Varki, 1997). Selectins are important during inflammation by mediating leukocyte 
adhesion, rolling and extravasation to the site of inflammation (Lasky, 1995; Varki, 1994). Milk 
oligosaccharides were shown to bear structures that resemble selectin ligands (Rudloff et al., 
2002). Furthermore in vitro experiments confirmed the inhibitory action of sialylated milk 
oligosaccharides on rolling and adhesion of leukocytes (Bode et al., 2004). Therefore small 
amount of milk oligosaccharides in circulation might reduce intestinal inflammation by binding to 
selectin ligands and thus protect against inflammatory diseases (Bode, 2009) or mediate cell 
growth or apoptosis by binding galectin ligands.  
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The gastrointestinal immune system 
The main function of the gastrointestinal tract is the absorption of nutrients, vitamins and water. 
To ensure optimal uptake the intestine is uniquely structured. Numerous complex foldings, the 
villi, enlarge the surface area up to 400 m2. This is 200 times more than the total skin surface 
area and guaranties maximal absorption (Brandtzaeg, 2009). Shortly after birth the intestine is 
colonized by microorganisms. Approximately 1014 microorganisms, mainly bacteria, live in 
symbiosis with their host (Backhed et al., 2005). The bacteria profit from the energy rich 
environment whereas the host is delivered with vitamins and short-chain fatty acids. Moreover, 
commensal bacteria impede the colonization of pathogens and help the developing immune 
system. However, the constant exposure to potential pathogens and food antigens requires 
tightly regulated immune responses to discriminate self from non-self and danger from harmless 
signals. Therefore, the intestine comprises the largest and most complex immune system of the 
body (Mowat, 2003). Specialized cells of both the innate and adaptive immune system are 
located in the gut associated lymphoid tissues (GALT) orchestrating the balance between 
tolerance and inflammation to achieve protection and homeostasis. 
 
Components of the mucosal immune system 
Epithelial layer 
The intestinal epithelium consists of a monolayer of columnar intestinal epithelial cells, the 
enterocytes. These cells are generated from stem cells in the crypt and migrate while maturing 
to the villus. Fully mature, they are equipped with enzymes for luminal and intracellular digestion 
and absorption. On the tip of the villi deceased cells are shed off in a cycle of 3-7 days in 
humans (Carethers, 1998). Specialized enterocytes, the goblet cells secrete mucus, high 
molecular weight glycoproteins, that overlay the intestinal layer providing a barrier for invading 
pathogens and neutralizing gastric acid (Specian and Oliver, 1991b). An additional epithelial cell 
lineage located to the crypts is the paneth cells. Through their release of antimicrobial peptides, 
they contribute immensely to the intestinal innate immunity by killing bacteria directly (Vaishnava 
et al., 2008). Intestinal cells that produce a wide range of hormones such as serotonin, motilin, 
cholecystokinin and vasoactive intestinal peptide are the so called endocrine cells (Flemstrom 
and Sjoblom, 2005). These cells are regulators of fluid and electrolyte secretion, motility and 
food intake by sensing luminal contents of nutrients, changes in osmolarity and acidity (Moran et 
al., 2008; Raybould, 2003). Interspersed among epithelial cells, specialized unconventional T 
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Isolated lymphoid follicles and cryptopatches 
The isolated lymphoid follicles are aggregations of lymphoid structures in the intestinal wall. 
They resemble Peyer’s patches and are additional inductive sites for mucosal T and B cells. 
Cryptopatches are clusters of lymphoid cells in the basal lamina propria (Brandtzaeg and Pabst, 
2004). Their occurrence is species specific and believed to represent precursors of isolated 
lymphoid follicles rather than being sites of extrathymic intraepithelial lymphocyte development 
as previously thought (Brandtzaeg et al., 2008; Onai et al., 2002). 
 
Mesenteric lymph nodes 
The mesenteric lymph nodes are the largest lymph nodes of the body. They are known to be the 
main site for oral tolerance induction (Mowat et al., 2004). Food antigens from the intestinal 
lumen are picked up by dendritic cells from the intestinal epithelium and from the subepithelial 
dome in the Peyer’s patches, migrate to the mesenteric lymph nodes where they are displayed 
to T cells for tolerance induction (Strobel and Mowat, 2006; Worbs et al., 2006). Despite this 
effect, mesenteric lymph nodes are the key players to preserve systemic ignorance to 
commensal bacteria. The mesenteric lymph nodes build a “firewall” compartmentalizing the 
mucosal from the systemic immune system (Macpherson and Uhr, 2004). Therefore, when 
bacteria are transported via dendritic cells to the mesenteric lymph nodes they are quickly 
eliminated by macrophages, preventing their systemic penetration (Macpherson and Smith, 
2006). 
 
Lamina propria 
The lamina propria is a thin layer of connective tissue underneath the epithelial layer. It is known 
to be the effector site of the mucosal immune system (Brandtzaeg and Pabst, 2004). More than 
80% of all plasma cells in the body are located to the lamina propria producing IgA amounts 
which exceed the total production of all other immunoglobulin isotypes combined (Fagarasan 
and Honjo, 2003; Macpherson and Harris, 2004). Dimeric IgA are transported through the 
epithelial layer to the intestinal lumen via receptor coupled vesicular transport (Brandtzaeg and 
Prydz, 1984). In the lumen, IgA opsonize bacteria and prevent their attachment to the epithelial 
layer and their invasion. T cells residing in the lamina propria are of an effector or memory 
phenotype. After priming in the mesenteric lymph nodes by antigen-loaded dendritic cells T cells 
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First line of defense 
The constant exposure of the gastrointestinal tract to foreign antigens demands specific physical 
adaption to prevent over reactions of the immune system. This is provided by the first line of 
defense which consists of extrinsic (outside the epithelial monolayer) and intrinsic (inside the 
epithelial monolayer) barriers between the epithelial cells and the environment.  
Gastric acid is part of the extrinsic chemical barrier. It lowers the pH in the gastrointestinal tract 
leading to a decrease in bacterial activity, an increase in bacterial cell wall lysis and an increase 
in detoxification of toxins (Giannella et al., 1972). Goblet cells in contrast provide the extrinsic 
physical barrier. They secrete high molecular weight glycoproteins, the mucins, that form a 
hydrated viscous layer (Maury et al., 1995). This mucosal blanket serves as a size selective 
diffusion barrier allowing small particles to pass while trapping bacteria inside (Frey et al., 1996). 
Bacteria are trapped in the mucus layer by binding to carbohydrate moieties of mucins that 
mimick epithelial cell membrane glycans used for pathogen adherence (Chadee et al., 1987) or 
by binding membrane component of pathogens such as type 1 pili of Escherichia coli (Sajjan 
and Forstner, 1990). The mucus containing bacteria is sequentially washed away through the 
peristaltic movements of the intestine to prevent their overgrowth and translocation (Pitman and 
Blumberg, 2000; Specian and Oliver, 1991a). 
The intrinsic physical barrier, the epithelial cell monolayer is maintained by two structural 
components: the brush border and the tight junctions. The brush border is formed by finger-like 
microvillar extensions on intestinal epithelial cell protecting their apical side. Intercellular tight 
junctions connect adjacent cells and regulate paracellular permeability. They are linked to the 
brush border through an actin filament network. Together they ensure strong membrane integrity 
and inhibit bacterial translocation (Artis, 2008; Shen and Turner, 2006; Turner, 2009; Wang and 
Andersson, 1994). The epithelial monolayer is constantly replaced by dividing cells in the crypt 
that move up towards the villi where they undergo apoptosis. This constant replacement 
eliminates infected or damaged cells rapidly (Potten et al., 1997). In the case of a chemical or 
toxic injury, the renewal and migration of intestinal epithelial cells toward injured sites is 
enhanced by intestinal trefoil factor, a peptide secreted into the mucous layer by goblet cells 
(Pitman and Blumberg, 2000; Podolsky, 1999). This rapid adaptation provides innate resistance 
against epithelial insults by maintaining cellular integrity. 
Another biochemical barrier is produced by the paneth cells located at the base of small 
intestinal crypts. They are specialized epithelial cells that store granules containing antimicrobial 
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the human colon. Firmicutes and Bacteroidetes are the dominant phyla whereas Actinobacteria, 
Proteobacteria, Fusobacteria and Verrucomicrobia are less abundant (modified from Sartor, 2008; 
Eckburg et al., 2005) 
 
Contributions of the microbiota 
The generation and housing of germ-free animals revealed important information about the 
effects that microbes exhibit on host physiology and pathology (Falk et al., 1998). Analysis of 
germ-free animals compared to conventionally raised animals showed structural and functional 
differences such as enlarged cecum, diffuse and underdeveloped gut associated lymphoid 
tissue and angiogenesis (Stappenbeck et al., 2002), altered gut epithelial cell turnover (Savage 
et al., 1981) and increased caloric intake (Wostmann, 1981). 
A major metabolic function of the intestinal microbiota lies in their capability to hydrolyse 
complex polysaccharide structures derived from a plant-rich diet (Savage, 1986). The limited 
repertoire of glycosylhydrolases in the mammalian genome is insufficient for optimal energy 
harvest. Microbes provide the needed saccharolytic enzymes digesting otherwise indigestible 
polysaccharides. Thus the microbiota ensures optimal energy uptake and allows rapid adaption 
to dietary changes (Duerkop et al., 2009; Hooper et al., 2002). Alteration in the composition of 
microbial divisions can lead to metabolic disorders such as obesity and diabetes. In obese 
individuals, for example, the proportion of Firmicutes to Bacteroidetes is shifted to a higher 
number of Firmicutes whereas in lean individuals Bacteroidetes are dominant (Ley et al., 2006b). 
End products of bacterial fermentation, the short chain fatty acids are the main source of energy 
for the colonic epithelial cells (Bergman, 1990). However not only do they deliver energy, they 
also promote proliferation and differentiation of intestinal crypt cells (McCullough et al., 1998). 
Furthermore, colonization studies with ex-germfree animals revealed an impact of the microbiota 
on the immune system. Germfree housed animals have extensive defects in the development of 
the gut-associated lymphoid tissues with fewer and smaller Peyer’s Patches and mesenteric 
lymph nodes, impaired development of isolated lymphoid follicles and lower antibody production 
(Bouskra et al., 2008; Macpherson and Harris, 2004). Intestinal microbes additionally provide 
signals for the development of key lymphocyte populations. They for example induce IgA class 
switching in intestinal B lymphocytes (He et al., 2007). Upon interaction with antigens presented 
by dendritic cells, CD4+ T cells can differentiate into a variety of effector subsets, namely Th1, 
Th2, Th17 and T regulatory cells in order to protect the host against different classes of 
pathogens (Zhou et al., 2009). Th1 cells are involved in cellular immunity against intracellular 
microorganisms, whereas Th2 cells helps clearing extracellular bacteria, fungi and helminthes 
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(Sallusto and Lanzavecchia, 2009). Th17 are especially important at musosal sites for the 
elimination of extracellular bacteria and fungi (Weaver et al., 2007). Regulatory T cells are 
crucial for immune homeostasis as they suppress immune activation by releasing anti-
inflammatory cytokines (Vignali et al., 2008). These T helper subsets were shown to be 
influenced by the composition of the microbiota. Thus, the microbiota regulated the balance 
between Th17 and Treg cells in the lamina propria (Bettelli et al., 2007; Ivanov et al., 2008). 
Furthermore the microbiota has an impact on systemic immune response by influencing the Th1 
and Th2 effector cells. Bacterial-derived polysaccharide A from the commensal Bacteroides 
fragilis was shown to affect systemic Th1 response by inducing CD4+ T cells proliferation and 
Th1 cytokine production (Mazmanian et al., 2005). 
 
Probiotics 
Probiotics were first described as nonpathogenic living microorganisms, which exhibit beneficial 
effects on host health and contribute to disease prevention (Lilly and Stillwell, 1965). Their 
properties are defined through their ability to resist gastric juice, pass through the 
gastrointestinal tract and proliferate in the gut in the presence of bile and anaerobic conditions. 
These criteria are mainly matched by Lactobacillus, Bifidobacterium and Saccharomyces 
(Holzapfel et al., 2001) although not excluding microorganisms from other genera such as E.coli 
Nissle 1917. Through improved techniques in microbial typisation and increasing evidence of the 
close interplay between the host genome and its microenvironment, probiotics have gained more 
attention in current research. The accumulated knowledge about the mechanisms, by which 
probiotics promote host health, makes their supplementation a possible treatment for microbiota 
associated diseases such as inflammatory bowel disease (Reiff and Kelly, 2010).  
 
Functions of probiotics 
Probiotics contribute to host homeostasis by different mechanisms. The following three 
approaches show how probiotics exhibit beneficial effect (Fig. 9). 
The first approach involves the production of short-chain fatty acids and antibacterial peptides, 
the so called bacteriocins. The short-chain fatty acids produced by certain probiotics during the 
anaerobic metabolism of carbohydrates create a low pH environment that limits bacterial growth 
(Louis et al., 2007). Bacteriocins are ribosomally synthesized antimicrobial peptides produced by 
one bacterium that kill other bacteria but simultaneously are immune to their own bacteriocins 
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(Riley and Wertz, 2003). Bacteriocins eliminate potential pathogens by pore formation in the 
cytoplasmic membrane of sensitive bacteria (Cotter et al., 2005; Vesterlund et al., 2004) 
Together with competitive inhibition of pathogen and toxin adherence to intestinal epithelial cells 
or mucus, probiotics act as a barrier against a potential pathogenic microbial environment 
(Candela et al., 2005; Collado et al., 2007). 
The second approach involves the regulatory effect of probiotics on immune function. One 
mechanism involves the enhancement of host adaptive immunity. Probiotics have the potential 
to prime intestinal dendritic cells to selectively activate B lymphocytes to produce IgA, that once 
transported into the lumen reduces bacterial penetration through the intestinal layer 
(Macpherson and Uhr, 2004). Intestinal dendritic cells are important in maintenance of tolerance 
towards commensal bacteria and the generation of an immune response against pathogens. 
They can sense the local microbe rich environment and use the signals for induction of an 
appropriate immune response (Coombes and Powrie, 2008). For example when recognizing 
bacteria of a probiotic or commensal nature, low-level immune response is induced 
characterized by low expression of costimulatory molecules or inflammatory cytokines. In 
contrast, when dendritic cells sense pathogens they are primed to mount high Th1 immune 
response (Braat et al., 2004; Veckman et al., 2004). Additional probiotics prime dendritic cells to 
produce anti-inflammatory cytokines such as IL-10 to down modulate Th1 response (Drakes et 
al., 2004). Thus, probiotics and commensal bacteria balance the immune system between pro- 
and anti-inflammatory mucosal immune response leading to mucosal immune homeostasis.  
The third approach involves the regulation of intestinal epithelial cell function by probiotics. A 
functional intestinal barrier is crucial for host protection. Probiotic E. coli Nissle 1917 for example 
was shown to upregulate tight junction proteins after enteropathogenic E. coli induced injury, 
thereby initiating tissue repair (Zyrek et al., 2007). The probiotics Streptococcus thermophilus 
and lactobacillus acidophilus were reported to protect intestinal barrier function by prevention of 
cytokine-induced increases of intestinal epithelial paracellular permeability (Resta-Lenert and 
Barrett, 2006). Epithelial cells are also directly influenced by probiotics by an enhanced 
production of cytoprotective heat shock proteins and antibacterial peptides such as β-defensins 
(Tao et al., 2008; Wehkamp et al., 2004). 
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A diverse set of pattern recognition receptors exists that can be categorized into secreted, 
cytosolic and transmembrane receptors. Secreted pattern recognition receptors such as. 
collectins and pentraxins, activate the pathways of the complement system and opsonize 
microbes for phagocytosis by immune cells (Bottazzi et al., 2010). Cytosolic pattern recognition 
receptors include the retinoic acid inducible gene I like receptors and the nucleotide-binding 
domain and leucine-rich repeat-containing receptors (Inohara et al., 2005; Meylan and Tschopp, 
2006). The nucleotide-binding oligomerization domain (NOD) receptors sense bacterial 
molecules produced during the degradation of the cell wall polymer peptidoglycan such as 
muramyl dipeptide (Fritz et al., 2006). Transmembrane pattern recognition receptors include two 
families, the Toll-like receptors (TLR) and C-type lectin receptor (Rakoff-Nahoum et al., 2004; 
Weis et al., 1998). The TLRs are the best characterized transmembrane pattern recognition 
receptors. They are expressed either on the plasma membrane or in endosomal/lysosomal 
organelles.  
Intestinal epithelial cells express pattern recognition receptors and respond to commensal 
bacteria. To limit inappropriate immune activation to commensal bacteria at the mucosal surface, 
pattern-recognition receptors exhibit restricted expression and are well regionally and 
functionally compartmentalized (Abreu, 2010) (Fig. 10). For example, the expression levels of 
TLR4 and TLR2 and the corresponding co-receptors CD14 and MD-2 are kept low in the 
intestinal epithelial cells and are therefore relatively unresponsive to their ligands (Abreu et al., 
2001; Melmed et al., 2003). Although TLR4 expression and signaling is thought to occur at the 
plasma membrane, TLR4 was also found in the Golgi apparatus (Hornef et al., 2002). Co-
localization experiments confirmed an interaction of internalized LPS with TLR4. This 
internalization of LPS was shown to be required for TLR4 signaling in the intestine (Hornef et al., 
2003). This compartmentalization points out another precaution in preventing nonspecific 
activation of TLR. Another mechanism to compartmentalize TLRs is by their expression at the 
basolateral surface of epithelial cells as seen by TLR5, the recognition receptor for flagellin. 
Thus stimulation of TLR5 requires trans-epithelial transport of bacterial flagellin or leakage of 
epithelial tight junctions. TLR localization therefore ensures activation only by bacterial invasion 
and prevents hyperresponsiveness at the mucosal surface (Gewirtz et al., 2001). Not only 
receptor location but also their function can be polarized. TLR9, the receptor for unmethylated 
CpG DNA, is expressed on both the apical and basolateral side of intestinal epithelial cells. 
TLR9 engagement on the apical side results in an inhibition of the NF-κB pathway whereas 
basolateral engagement activates the pathway and induces a pro-inflammatory response (Lee et 
al., 2006).  
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An additional control of TLR activation is provided by negative regulators of Toll-like receptor-
mediated signaling. Toll-interacting protein inhibits IL-1 and NF-κB activation during TLR2 and 
TLR4 engagement though suppression of kinase activity of IRAK (Zhang and Ghosh, 2002). The 
single immunoglobulin IL-1R-related molecule functions as a decoy receptor interfering with the 
recruitment of downstream adaptors to the TLR complex during TLR4 and TLR9 signaling (Wald 
et al., 2003). The peroxisome proliferator activated receptor-γ also negatively regulates NF-κB 
activation in a TLR4 dependant manner (Dubuquoy et al., 2003). The prolonged exposure of 
TLR ligands or of microbiota extracts upregulate the expression of both inhibitors Toll-interacting 
protein and peroxisome proliferator-activated receptor-γ (Kelly, 2004; Melmed et al., 2003). 
Thus, they down-regulate TLR activity in response to the continual exposure of intestinal 
epithelial cells to commensal bacteria enforcing tolerance. In contrast to pathogenic bacteria, 
commensals are also able to directly down-regulate pro-inflammatory responses by mechanisms 
such as blocking the NF-κB pathway through inhibition of I-κB ubiquitination (Kelly, 2004; Neish, 
2000). 
Apart from TLR mediated upregulation of inflammatory cytokines via the NF-κB pathway, TLRs 
are also involved in the induction of IgA and antimicrobial peptides, and repair of epithelial cell 
injury through the induction of proliferation and tight junctions. A beneficial role in maintaining 
intestinal homeostasis was shown by deletion of TLRs or the adaptor protein MyD88 as the 
corresponding knock-out mice are not protected from intestinal inflammation (Abreu, 2010). 
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America and Europe, the exact cause of the disease has not yet been elucidated. However, 
there is a general agreement that a complex interplay between genetic, environmental and 
immunological factors is involved in disease initiation and progression (Bouma and Strober, 
2003; Sartor, 2008; Sokol et al., 2008). 
It is believed that innate immune response to commensal bacteria plays an important role in the 
initiation of IBD and in the development of pathological adaptive immune responses. Hence, an 
imbalance between pathogenic and protective microorganisms or a loss of gut bacteria that 
promote tolerance and regulatory T cell polarization could lead to an aberrant inflammatory 
response. As a result hyperresponsive Th1 or Th2 cells develop seen in Crohn’s disease and 
ulcerative colitis (Podolsky, 2002). 
Genetic factors have been investigated by genome-wide searches for IBD susceptibility gene 
loci. The first one identified was NOD2 followed by others such as IBD5, IL23R and ATG16L1 
(Duerr, 2006; Hampe, 2007; Hugot et al., 2001; Ogura, 2001; Silverberg, 2007). Interestingly all 
these genes were implicated in innate immunity, phagocytosis or autophagy. NOD2 mutation in 
patients with Crohn’s disease showed impaired NF-κB activation, a key transcription factor 
involved in inflammation and immune processes. Moreover Crohn’s disease patients have 
reduced expression of the antimicrobial peptide β-defensin, leading to enhanced bacterial 
translocation (Wehkamp et al., 2005). Additional polymorphisms and altered expression patterns 
of TLRs were detected in patients with IBD (Cario and Podolsky, 2000; Franchimont, 2004). This 
illustrates that the homeostasis between microbes and in particular the commensal flora and 
host immune response at the mucosal site is crucial particularly in preventing the pathogenesis 
of IBD. This hypothesis was supported by the beneficial effects of antibiotic treatment in some 
patients during active IBD and the amelioration of the disease after probiotics administration 
(Sartor, 2004). Furthermore, animal models of spontaneous colitis are entirely dependent on the 
presence of the microbiota as they remain healthy in a germfree environment (Horwitz, 2007). 
Unfortunately to date there is no cure for IBD. However, new insights in the pathogenesis of IBD 
revealed potential therapeutic approaches, of which some are now being tested in clinical trials. 
These include therapeutics in T cell polarization/differentiation, modulation of inflammatory 
cytokines/pathways such as blockage of the inflammatory cytokine TNF-α, inhibition of leukocyte 
infiltration, intestinal barrier repair and probiotics (Korzenik and Podolsky, 2006). Moreover, 
selected oligosaccharides are promising new candidates in the treatment of IBD. They function 
as prebiotics that alter the intestinal microbial composition by stimulating the growth of protective 
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bacteria. They enhance colonization resistance of disease-inducing bacteria and contribute to a 
reduction in colitis (Gibson et al., 2004; Looijer-Van Langen and Dieleman, 2009). 
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Abstract 
Milk oligosaccharides contribute to the development of the intestinal environment by acting as 
decoy receptors for pathogens and as prebiotics, which promote the colonization of commensal 
bacteria. The role of the sialylated milk oligosaccharides sialyl(α2,3)lactose and 
sialyl(α2,6)lactose on mucosal immunity was investigated in α2,3- and α2,6-sialyltransferase-null 
mice deficient for one type of milk sialyllactose. The exposure of newborn mice to milk 
containing or deficient for sialyllactose had no impact on the development of mucosal leukocyte 
populations. However, when adult mice were challenged by dextran sulfate sodium (DSS) in 
drinking water, mice previously exposed to sialyl(α2,3)lactose-deficient milk were more resistant 
to colitis compared to mice exposed to normal milk and sialyl(a2,6)lactose-deficient milk. The 
analysis of intestinal microbiota showed different colonization patterns depending on the 
presence or absence of sialyl(α2,3)lactose in the milk. The relationship between intestinal 
microbiota and the severity of DSS-induced colitis was established by showing that germfree 
mice reconstituted with intestinal microbiota isolated from mice fed on sialyl(α2,3)lactose- 
deficient milk were more resistant to DSS-induced colitis than germfree mice reconstituted with 
standard intestinal microtiota. The study demonstrated that the exposure to sialyllactose during 
infancy affects the bacterial colonization of the intestine, which directly influences the 
susceptibility to DSS-induced colitis in adult mice. 
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Introduction 
Oligosaccharides represent a major fraction of milk constituents. Unique among mammals, 
human milk contains a tremendous diversity of oligosaccharide structures, which are shaped by 
extension of lactose through glycosyltransferase enzymes in the mammary gland (Egge, 1993). 
The most abundant structures are the trisaccharides produced by addition of fucose or sialic 
acid to lactose. Whereas fucosylated oligosaccharides are missing from most mammalian milks, 
sialylated oligosaccharides are more widely distributed (Urashima et al., 2001). Since milk 
oligosaccharides are neither digested, nor absorbed in the small intestine (Brand Miller et al., 
1995), they have been suggested to contribute to the development of the infant gastrointestinal 
tract and its colonization by commensal bacteria (Frank and Pace, 2008; Savage, 1977). 
Milk oligosaccharides influence the development of the intestinal microbiota by acting as 
selective nutrients, which support the proliferation of specific bacterial groups (Gibson and 
Roberfroid, 1995). The prebiotic action of milk oligosaccharides has been demonstrated by 
comparing the intestinal microbiota of infants fed on oligosaccharide-rich breast milk and infants 
fed on formula (Harmsen et al., 2000). Furthermore, considering the structural similarity of milk 
oligosaccharides with cell surface glyans, milk oligosaccharides can function as soluble 
receptors, thereby preventing the attachment of pathogenic bacteria to intestinal epithelial cells 
(Newburg, 2009). 
Commensal bacteria are mainly found in the large intestine, consisting predominantly of the 
phyla Firmicutes and Bacteroidetes (Eckburg et al., 2005). Firmicutes themselves are composed 
of two major clostridial groups, namely the clostridial cluster IV and clostridial cluster XIVa, which 
comprises Lachnospiraceae. The density and diversity of the intestinal microbiota are highly 
complex. Culture-independent methods have allowed to estimate the presence of 500-1000 
different species and over 7000 strains in the human gastrointestinal tract (Dethlefsen et al., 
2007; Ley et al., 2006). Commensal bacteria are indispensible for the proper development of the 
mucosal immune system. In addition to morphological development of immune compartments, 
bacterial colonization initiates antibody production (Macpherson and Harris, 2004) and the 
production of antimicrobial proteins such as defensins (Falk et al., 1998). Bacterial cell wall 
components have also been shown to regulate CD4+ T helper cell activity in the lamina propria 
(Gaboriau-Routhiau et al., 2009). On the other hand, a defect of the innate immune system has 
been shown to affect the composition of the intestinal microbiota in mice and thereby contributes 
to metabolic imbalance (Vijay-Kumar et al., 2010). In humans, similar relationships have been 
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established between the intestinal microbiota and energy balance, thus leading to the definition 
of microbiomes typical for disorders such as obesity (Turnbaugh et al., 2006). 
Prebiotic oligosaccharides have been claimed to reduce the susceptibility to allergies in infants 
(Hoffen et al., 2009; Moro et al., 2006) and shown to influence the immune response to 
vaccination in mice (Vos et al., 2007). However, the mechanisms underlying the regulatory 
action of oligosaccharides remain largely unknown. Considering the structural complexity of 
human milk oligosaccharides, the mouse with its reduced range of milk oligosaccharides (Prieto 
et al., 1995) enables addressing the functional impact of specific oligosaccharides on mucosal 
immunity in vivo. In the present study, we have studied the impact of sialylated oligosaccharides 
using sialyltransferase-knockout mice deficient for these milk oligosaccharides. The fostering of 
newborn mice by normal or sialyllactose-deficient mothers allowed demonstrating the 
importance of this type of milk oligosaccharides on the colonization of intestinal bacteria and on 
the susceptibility to an experimental colitis model. 
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Results 
The sialyltransferase enzymes St6gal1 and St3gal4 are responsible for the production of 
sialyllactose in mouse milk. 
The composition of mouse milk oligosaccharides is limited to sialyllactoses with only traces of 
fucosylated lactose (Kuhn, 1972; Prieto et al., 1995). This low structural complexity makes the 
mouse a suitable model to investigate the role of these specific milk oligosaccharides on 
mucosal immunity. Because multiple α2,3 and α2,6 sialyltransferase enzymes (Harduin-Lepers 
et al., 2001) could be responsible for the production of sialyllactose, we have first examined the 
expression of these genes in the lactating mammary gland. The mRNA levels of the α2,3 
sialyltransferase genes St3gal1 to St3gal6 and of the two α2,6 sialyltransferase genes St6gal1 
and St6gal2 were determined by real-time PCR . The expression of the St6gal1 gene was 
induced up to 20-fold during lactation, suggesting this sialyltransferase may account for the 
biosynthesis of sialyl(α2,6)lactose (6SL) (Fig. 1) and thus confirming a previously published 
observation (Dalziel et al., 2001). Among α2,3 sialyltransferase genes, the expression of St3gal1 
and St3gal4 were induced by 3- and 4-fold during lactation, respectively (Fig. 1). The three 
St6gal1, ST3gal1 and St3gal4 represented also the most abundant sialyltransferase transcripts 
in lactating mammary gland when mRNA levels were normalized to GAPDH (data not shown). 
To confirm the involvement of the St3gal1, St3gal4 and St6gal1 sialyltransferases in the 
production of milk sialyllactose, the oligosaccharide composition of milk isolated from St3gal1, 
St3gal4 and St6gal1 sialyltransferase-deficient mice was determined by pulsed amperometry-
HPAEC. Milk isolated from St3gal1-null mice showed unaffected or rather increased levels of 
both sialyl(α2,3)lactose (3SL) and 6SL when compared to the levels measured in wildtype (Wt) 
mice by day two of lactation (Fig. 2A). The analysis of oligosaccharides in milk from St3gal4-null 
mice showed a strong decrease of 3SL, indicating that this sialyltransferase accounts for the 
bulk of 3SL production. The importance of St6gal1 in the production of 6SL was confirmed by 
the absence of this oligosaccharide in the milk isolated from St6gal1-null mice (Fig. 2A). The 
impact of St3gal4 on 3SL production was investigated in more details by measuring sialyllactose 
levels across lactation. In Wt mice, 3SL levels peaked in the first week of lactation and slowly 
decreased until day 20, where only minor concentrations were detected. By contrast, 6SL levels 
showed only a modest increase by mid-lactation (Fig. 2B). The 3SL peak by the first week of 
lactation was absent in the milk of St3gal4-null mice and 3SL levels remained low across 
lactation, thus demonstrating the importance of St3gal4 for the biosynthesis of 3SL (Fig. 2C). 
The identity of 3SL and 6SL and exact structure of sialic acid in mouse milk were also analyzed 
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after release by neuraminidase treatment. We did find that milk sialyllactose was exclusively 
composed of N-acetylneuraminic acid since no N-glycolylneuraminic acid could be detected 
(data not shown). 
Feeding with milk deficiency in 3SL increases the resistance of mice to dextran sulfate 
sodium-induced colitis 
The role of milk 3SL and 6SL onto the development of the mucosal immune system was 
addressed by feeding Wt and St3gal4-null newborn mice with normal or with 3SL-deficient milk 
as achieved by cross-fostering litters with Wt and St3gal4-null mothers. The same cross-
fostering approach was applied to study the role of 6SL. Leukocyte populations and IgA 
secretion were determined in three-, six- and twelve-week old mice by flow cytometry and 
enzyme-linked immunosorbent assay, respectively. The T-cell specific markers TCRαβ/γδ, CD4, 
CD8 and CD8αα/αβ were measured in Wt, St3gal4-null, St6gal1-null and correspondingly cross-
fostered mice. No differences were noticeable for leukocyte populations and IgA secretion, 
indicating that neither the feeding with sialyllactose-deficient milk, nor the disruption of the 
St3gal4 and St6gal1 genes had any impact on the maturation of intestinal leukocytes. 
In a second approach, we have addressed whether feeding with 3SL- and 6SL-deficient milk 
affected the response of mice to an intestinal challenge. At seven weeks of age, mice were 
exposed to dextran sulfate sodium (DSS) in drinking water for five days. DSS impairs the 
integrity of intestinal barrier, thereby inducing an acute colitis (Okayasu I, 1990). Wt mice 
responded strongly to the treatment as shown by a loss of body weight of 17% by day seven. By 
contrast, St3gal4-null mice were more resistant to DSS as they lost only 5% of their body weight 
by day seven (Fig. 3A). Wt mice that were cross-fostered and fed with 3SL-deficient milk 
sustained the DSS treatment better than those fed with normal milk, as shown by a reduced loss 
of body weight of 8%. Correspondingly, St3gal4-null mice fed with normal milk were more 
susceptible to DSS-induced colitis than littermates fed with 3SL-deficient milk (Fig. 3A). DSS-
induced colitis in St6gal1-null mice lead to a similar disease as found in Wt mice. Accordingly, 
cross-fostering experiments with normal and 6SL-deficient milk had no impact on the 
susceptibility to acute colitis (data not shown). We therefore focused on the investigation of 3SL 
in colitis development. 
The severity of colitis was also registered by measuring colon length and epithelial permeability. 
At day seven, colon length was shortened by 20-25% in Wt mice, whereas it was shortened by 
10% in St3gal4-null mice (Fig. 3B). Cross-fostered mice showed a degree of colon shortening 
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that matched the loss of body weight. Wt mice fed with 3SL-deficient milk showed only a 10% 
colon shortening and St3gal4-null mice fed with normal milk showed a more pronounced colon 
shortening (Fig. 3B). A similar picture was obtained by examining epithelial permeability in the 
intestine. DSS treatment increased epithelial leakiness in Wt mice but not in St3gal4-null mice. 
The finding was reversed when looking at cross-fostered Wt and St3gal4-null mice fed with 3SL-
deficient and normal milk, respectively (Fig. 3C). The severity of colitis was also appreciated by 
measuring the inflammatory cytokines TNFα, IL-1β and IL-6. The levels of TNFα and IL-1β 
expression were not elevated by day seven but IL-6 expression was induced 59-fold  in mice, 
which had been fed with normal milk, whereas IL-6 expression was less pronounced, around 25-
fold, in mice exposed to 3SL-deficient milk (Fig. 3D-F). 
The extent and types of cells infiltrating the inflamed colons were analyzed by flow cytometry in 
Wt, St3gal4-null mice and correspondingly cross-fostered mice. By day five, 27 to 40% of cells 
recovered from the lamina propria were CD45+ (Fig. 4). By day 7, additional 5-10% CD45-
positive cells were detected (Fig. 4A). Leukocyte infiltration was highest in mice fed with normal 
milk, but infiltration was only slightly decreased in mice that had been fed with 3SL-deficient milk 
(Fig. 4B). The CD45+ cells were identified as B cells (68%, CD19+) and granulocytes (20%, Gr1+) 
with a minor population of T cells (7%, CD3+). The contribution of St3gal4-null leukocytes to the 
resistance towards DSS-induced colitis was tested on irradiated Wt mice transplanted with 
St3gal4-null bone marrow and irradiated St3gal4-null mice transplanted with Wt bone marrow.  
After transplantation, mice were given seven weeks to recover from mucosal injury sustained 
during irradiation before being subjected to DSS treatment. Wt mice bearing immune cells from 
St3gal4-null mice rapidly developed colitis and reached the critical weight loss of 15% whereas 
St3gal4-null mice with Wt leukocytes showed only 3% weight loss (Fig. 4C). We thus concluded 
that the resistance to DSS-induced colitis was independent of the leukocyte genotype. 
Feeding with 3SL-deficient milk modifies the bacterial colonization of the mouse intestine 
We did show so far that the exposition to milk in the first three weeks of life had an impact on the 
susceptibility to DSS-induced colitis tested in adult mice. Considering the known effect of milk 
oligosaccharides as prebiotics (Bode, 2009), we addressed whether the presence or absence of 
3SL affected the composition of the intestinal microbiota and thereby the outcome of DSS-
induced colitis. To address the first point, we fingerprinted the intestinal microbiota of Wt, 
St3gal4-null and cross-fostered mice by temporal temperature gradient gel electrophoresis 
(Livak and Schmittgen) and by real-time PCR. TTGE fingerprints from each six mice of each 
group were analyzed at three, six (Fig. 5A) and twelve weeks of age. Despite internal differences 
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within groups, cluster analysis indicated a higher degree of similarity within than between these 
groups. A specific band, identified by sequencing as representing a Ruminococcaceae species, 
was only identified in the microbiota of mice exposed to 3SL, namely in Wt mice and in St3gal4-
null mice fed with Wt milk (Fig. 5A). The sequence obtained from the TGGE band indicated that 
the Ruminococcaceae species was very close to Ruminococcaceae from the clostridial cluster 
IV, yet different from the species known to date. By comparison, the presence or absence of 6SL 
as tested with St6gal1-null mice did not affect the occurrence of the Ruminococcaceae in the 
intestinal microbiota (data not shown), indicating that these bacteria require 3SL for gut 
colonization. 
The diversity of the intestinal microbiota was also determined during DSS-induced colitis. A 
lower amount of bands on the gels were detected in DSS-treated mice compared to healthy 
animals indicating a decrease of microbial diversity (Fig. 5B). The band distribution on the gel 
was also shifted in mice treated with DSS, showing a change in microbial composition. 
Interestingly the Ruminococcaceae-related band remained unchanged during colitis. The real-
time PCR analysis of the five phylogenic groups Enterobacteriaceae, Lachnospiraceae, 
clostridial cluster IV, Bacteroidetes and Lactobacillaceae in Wt, St3gal4-null and cross-fostered 
mice confirmed that 3SL deficiency in the milk only affected the colonization of clostridial cluster 
IV bacteria (Fig. 6A). However, during DSS-induced colitis, the previous exposure to 3SL in milk 
influenced the relative composition of Enterobacteriaceae and the clostridial cluster IV to total 
bacteria. Enterobacteriaceae and the clostridial cluster IV were more abundant in Wt and cross-
fostered St3gal4-null mice after DSS treatment (Fig. 6B).  
Considering the differential detection of a Ruminococcaceae species by TTGE analysis and the 
fact that several Ruminococcaceae are part of the clostridial cluster IV (Van Dyke and McCarthy, 
2002), we have measured the abundance of these bacteria using PCR primers that specifically 
target 16S rRNA from Ruminococcus genera. In agreement with the TTGE data, 
Ruminococcaceae were more abundant in mice that had been exposed to 3SL containing milk, 
i.e. in Wt and cross-fostered St3gal4-null mice (Fig. 6C). The treatment with DSS did not alter 
the levels of Ruminococcaceae, thereby confirming the TTGE findings (Fig. 5B). 
Microbiota isolated from mice fed with 3SL-deficient milk increase the resistance of 
reconstituted germfree mice to DSS-induced colitis  
To demonstrate that the effect of 3SL-deficiency towards DSS treatment was mediated by 
selective bacterial colonization of the intestine, we have reconstituted germfree mice with 
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intestinal microbiota isolated from the cecum of Wt and St3gal4-null mice. Colonization success 
was confirmed by TTGE analysis of fecal pellets two weeks after reconstitution. The microbiota 
from Wt mice included the Ruminococcus-related specific band, whereas the microbiota from 
St3gal4-null mice lacked this major band (Fig. 7A). The mice with reconstituted microbiota were 
then subjected to DSS treatment by twelve weeks of age. The mice with the Wt derived 
microbiota showed a progressive loss of body weight similar to Wt mice, reaching 82% of their 
initial body weight by day seven (Fig. 7B). By contrast, the mice with the St3gal4-null derived 
microbiota showed a moderate weight loss to 90% of initial body weight, thus demonstrating that 
the composition of the intestinal microbiota had a direct influence on the susceptibility to DSS-
induced colitis. 
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Discussion 
The present study demonstrated the impact of the milk sialyllactose 3SL on the colonization of 
the murine intestinal microbiota and thereby on the susceptibility to DSS-induced colitis. The 
application of the cross-fostering setup between Wt and St3gal4-null mice demonstrated for the 
first time that a single oligosaccharide structure influences microbial composition in vivo. The 
different abundance of specific bacterial groups like Ruminococcaceae in mice fed with normal 
or 3SL-deficient milk correlated with the susceptibility to DSS-induced colitis. The first question 
arising when considering the model investigated is whether the oligosaccharide 3SL exerts 
regulatory functions on the mucosal immune system, thereby influencing the immune response 
to DSS exposure. Our survey of leukocyte populations did not reveal any differences between 
Wt, St3gal4-null and cross-fostered mice, thus speaking against such an immunoregulatory 
effect of 3SL. Furthermore, the bone marrow transplantation between Wt and St3gal4-null mice 
showed that the susceptibility to DSS did not correlate with the genotype of leukocytes. Finally, 
the differential susceptibility of reconstituted germfree mice to DSS demonstrated that the effect 
of 3SL-deficient milk was mediated by microbiota and not by the mucosal immune system.  
The exposure to 3SL during lactation could influence the colonization of intestinal bacteria by 
affecting their adhesion to the intestinal epithelium or by serving as nutrients for specific groups 
of bacteria. Milk 3SL could impair the attachment of bacteria binding to sialylated surfaces 
(Sakarya et al., 2003) or induce phase variation, thereby decrease type 1 fimbriae expression on 
some bacteria (Sohanpal et al., 2004). However, we could not address such an effect of 3SL on 
the colonization of Ruminococcaceae, since we did not succeed yet at isolating this bacterial 
group in culture. Alternatively, 3SL could be used as a carbon and nitrogen source, which would 
facilitate the proliferation of bacteria capable of metabolizing sialic acid, as shown for the 
intestinal colonization of E. coli and V. cholera (Almagro-Moreno and Boyd, 2009b; Chang et al., 
2004). Noteworthy, the Nan-cluster of genes required for the catabolism of sialic acid is found in 
several pathogenic and commensal bacteria including Ruminococcus gnavus (Almagro-Moreno 
and Boyd, 2009a). Thus the selective colonization of Ruminococcaceae in the presence of 3SL 
might be mediated through their ability to use 3SL for energy gain. 
The gram-positive Ruminococcaceae are obligate anaerobes that are commonly found in the 
colon of mammals including mice and humans (Collins et al., 1994). Ruminococcaceae are 
known to ferment polysaccharides like cellulose and starch (Herbeck and Bryant, 1974; Leitch et 
al., 2007; Wang et al., 1997). The correlation between the abundance of the Ruminococcus-
related species and the susceptibility to DSS-induced colitis suggests that this bacterium may 
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have a pro-inflammatory action. The fact that Ruminococcaceae have been found enriched in 
patients with inflammatory bowel disease (Andoh et al., 2007; Martinez-Medina et al., 2006; 
Pirindiville et al., 2004) supports their potential role as pro-inflammatory bacteria. Moreover, the 
intestinal colonization of Ruminococcaceae may impair the settlement of other bacterial groups, 
which are known to attenuate the extent of the inflammatory response (Im et al., 2009; Kumar et 
al., 2008) 
At the present stage, it is not possible to demonstrate a direct relationship between the intestinal 
abundance of Ruminococcaceae and the severity of DSS-induced colitis. The isolation and 
culture of Ruminococcaceae in vitro would allow the selective reconstitution of germfree mice 
with these bacteria and subsequently to address the susceptibility of the mice to DSS treatment. 
We are currently trying to enrich for Ruminococcaceae on 3SL-containing media in order to 
assess their exact role in the development of colitis.  
Our study has demonstrated that the exposure to a single milk oligosaccharide structure can 
significantly influence intestinal bacterial colonization and thereby affect the susceptibility of the 
host to DSS-induced colitis. The fact that mice fed with 3SL-deficient milk were more resistant to 
DSS treatment is somehow paradoxical, considering that this oligosaccharide is evolutionary 
conserved in most mammals. Although 3SL has a pro-inflammatory effect in the DSS model, it 
can be assumed that 3SL may mediate protective actions, as for example by preventing the 
adhesion of pathogenic viruses and bacteria during infancy. Further, the 3SL dependent 
microbiota might confer an evolutionary advantage by promoting an inflammatory defense 
reaction upon an infection challenge. The fact that 3SL levels in milk are elevated in the first 
days postpartum and strongly decrease until weaning may indicate the need for a balanced 
availability of the oligosaccharide in the developing gastrointestinal tract. The study of additional 
immunological challenges and infectious models in sialyltransferase-null mice will further clarify 
the biological importance of sialylated milk oligosaccharides in the physiology of the 
gastrointestinal tract. 
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Matherials and methods 
Mouse models - Sialyltransferase St6gal1-null (Hennet et al., 1998), St3gal1-null (Priatel et al., 
2000) and St3gal4-null (Ellies et al., 2002) were  provided by Dr. Jamey Marth (University of 
California Santa Barbara, USA). All mice were in the C57Bl/6 background. Sialyltransferase-null 
and Wt control mice were housed in light-cycled and climate-controlled rooms. All experiments 
were performed in compliance with the Swiss Animal Protection Ordinance and approved by the 
local veterinary authority (Kantonales Veterinäramt Zürich, Switzerland). Synchronized matings 
were setup for sialyltransferase and Wt control mice to allow the exchange of newborn mice for 
cross-fostering experiments. To this end both the mothers and the litter of the other genotype 
were transferred to new cages including parts of the mother’s nests. 
Sialyltransferase gene expression in mammary glands - Commercial RNA (Axxora Ltd., UK) 
isolated from mammary glands of virgin mice and mice after one and two weeks postpartum and 
three days post weaning was used to monitor sialyltransferase expression profiles by real-time 
PCR using a SybrGreen protocol. Briefly, RNA samples were treated with DNase (DNA-Free, 
Ambion, USA) according to manufacturer’s instructions. Reverse transcription (RT) reactions 
were performed with 2 µg of total RNA and random hexamer primers using the Thermoscript 
RT-PCR System (Invitrogen, USA) according to manufacturer’s instructions. Real-time PCR 
reactions were performed using the SYBR Green PCR Master Mix (Applied Biosystems, USA) of 
24 µl and 1 µl of test cDNA per reaction. The primers used for amplification of mouse 
sialyltransferase genes are given in table 1. After an initial denaturation step of 10 min at 95°C, 
40 cycles at 95°C for 15 s, 60°C for 1 min and 72°C for 1 min. Gene expression was normalized 
to GAPDH expression calculations were done according to the 2-Ct method (Livak and 
Schmittgen, 2001). 
Mouse milking - Lactating mothers were separated from their suckling newborns for four hours. 
Milk ejection was stimulated by intraperitoneal injection of 0.5 IU of oxytocin (Sigma, 
Switzerland). Mice were anesthetized by ketamine (0.65 ml/kg) and xylazine (0.5 ml/kg). Milk 
was collected by aspiration (Haberman, 1974; Nagasawa, 1979), then frozen and lyophilized. 
Dry matter was determined by weighing and samples were resuspended in water to yield a stock 
solution of 100 mg/ml. 
Milk oligosaccharide analysis - For each sample an equivalent of 16.5 µg dry matter was 
separated on a CarboPac PA200 analytical column (Dionex, Sunnyvale, CA, USA) with an 
aminotrap guard (Dionex) using a high performance anion exchange chromatography system 
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ICS3000 (Dionex) equipped with a pulsed amperometry detector. The column compartment was 
set to 25°C and the flow speed to 0.38 ml/min. The running conditions were as follows: isocratic 
30 mM NaOH (J.T.Baker, NL) for 10 min followed by a linear gradient to 100 mM NaOH for 10 
min followed by isocratic 100mM NaOH for 10 min and a linear gradient from 0 to 100 mM Na-
acetate (Merck, D) for an additional 35 min. Each run was preceded by a washing and 
equilibration step: isocratic 500 mM Na-acetate for 5 min followed by isocratic 300 mM NaOH for 
10 min followed by isocratic 30mM NaOH for 10 min. The retention times for 6SL and 3SL were 
38.3 min and 38.7 min, respectively. Peak identification was done based on retention time 
comparison with authentic external sialyllactose standards (Dextra laboratories, UK) and 
disappearance of sialyllactose peaks upon neuraminidase treatment with simultaneous 
appearance of N-acetylneuraminic acid. For quantification, a standard curve with 50, 100 and 
250 ng authentic 6SL and 3Sl standards was established before and after injection of five milk 
samples. 
DSS induced colitis - Seven week old, sex matched mice were treated with 3.75% (w/v) DSS 
(molecular mass = 36-50 kD; MP Biomedicals, France) in drinking water for 5 days followed by a 
supply of normal water until sacrifice of the animals (Okayasu I, 1990). The lowest possible DSS 
dosage was chosen to achieve acute inflammation within 7 days. Body weight and physical 
activity were monitored daily. Animal pain was kept to a minimum by following the Swiss Animal 
Protection Ordinance and euthanizing animals reaching less than 85% of initial body weight. 
Transepithelial permeability assay - Mice were gavaged with 60 mg/100 g body weight of FITC-
dextran (MW 3,000-5,000, Sigma) (Napolitano et al., 1996). Mice were sacrificed and blood was 
isolated by cardiac puncture. Serum fluorescence (485/535 nm) was measured immediately 
using a Genios Multi-Detection Microplate Reader (Tecan, Switzerland). Concentrations were 
calculated from standard curves using serial dilutions of FITC-dextran in serum. 
Cytokine gene expression - RNA from frozen colon tissue was isolated using the RNeasy 
Protect Mini Kit (Qiagen) according to the manufacturer’s instructions. RT was performed with 2 
µg total RNA using oligo(dT) primers and an Omniscript RT kit (Qiagen, USA). Real-time PCR 
was carried out using SYBR Green JumpStart Taq ReadyMix (Sigma, Switzerland) with specific 
primers for IL-1, IL-6, TNFα and GAPDH (QuantiTec Primer, Qiagen, USA) in a Mx3000P 
thermocycler (Stratagene, USA). Cycling conditions were 40 cycles at 95°C for 15 s, 60°C for 30 
s and 72°C for 30 s after initial denaturation at 95°C for 10 min. Gene expression was 
normalized to GAPDH expression using the 2-Ct method. 
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Lamina propria leukocyte isolation - Colon lamina propria leukocytes were isolated as described 
previously (Lefrançois and Lycke, 2003). Briefly, to detach intraepithelial lymphocytes, chopped 
colon segments were incubated 2 x 30 min at 37°C under constant stirring condition in 50 ml of 
Ca2+- and Mg2+-free Hanks’ balanced salt solution containing 10 mM HEPES, 2% horse serum, 2 
mM DTT and 0.5 mM EDTA. Leukocytes were released by additional incubation with 0.5 mg/ml 
of collagenase type IV (Sigma, Switzerland) and 30 µg/ml of DNAse I (Sigma, Switzerland) for 2 
x 45 min at 37°C and cells were filtered through a 70 µm nylon mesh cell strainer.  
Flow cytometry – Cells were stained on ice for 30 min with anti-CD45 APC-Cy7, anti-CD19 APC, 
anti-CD3 FITC, anti-Gr.1 PE, anti-TCRγδ PE, anti-TCRβ APC, anti-CD4 PE, anti-CD8β PE and 
anti-CD8α APC antibodies (BD Biosciences, USA) and analyzed with a FACSCanto II flow 
cytometer (BD Biosciences, USA). 
Bone marrow transfer - Ten week old male Wt and St3gal4-null recipient mice were lethally 
exposed to 9.33 Gy radiations (3.11 Gy/min). Femur and tibia from Wt and St3gal4-null donor 
mice were removed and flushed with RPMI 10% FCS (GIBCO, USA) to harvest BM cells. 
Irradiated recipient mice were reconstituted with 2 x 106 BM cells by intravenous injection 
(Spangrude, 2008). Mice were treated with antibiotics (Borgal® 24 % ad us. vet.,Veterinaria AG, 
Zürich, Switzerland) for 3 weeks.  
Temporal temperature gradient gel electrophoresis – DNA was isolated from freshly isolated 
cecal content using the QIAamp DNA Stool Mini Kit (Qiagen, USA). Bacterial 16S rRNA DNA 
was amplified using the universal primers HDA1-GC 5’-
CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCACGG-
GGGGACTCCTACGGGAGGCAGCAGT-3’ and HDA-2 5’-GTATTACCGCGGCTGCTGGCAC-3’ 
according to Ogier (Ogier et al., 2002). The PCR conditions were 30 cycles at 94°C for 30 s, 
56°C for 30 s, 72°C for 1 min flanked by an initial denaturation at 94°C for 4 min and a final 
elongation at 72°C for 4 min. PCR products were loaded on 8.5% polyacrylamide gels 
containing 8 M urea and separated by temperature gradient gel electrophoresis using the D-
Code universal mutation detection system (Bio-Rad, USA). Electrophoresis was performed in 60 
mM Tris-acetate, 30 mM acetic acid and 1.5 mM EDTA first at 20 V for 15 min followed by at 
constant voltage of 80 V for 18 hours with a temperature increase of 0.2°C/h from 66 to 70°C. 
TTGE profiles were analyzed by using GelCompar II software (Applied Maths NV, Belgium). 
Bacterial typisation –TTGE bands were excised from the gels and DNA was diffused over night 
at 4°C in 100 µl H2O. Standard HDA primers were used to reamplify the PCR product from 3 µl 
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of eluate. PCR products were purified using QIAquick PCR purification kit (Qiagen) and 
sequenced (Synergene Biotech, Switzerland). The proportion of bacterial phyla in intestinal 
samples was determined by real-time PCR using the SYBR Green JumpStart Taq ReadyMix 
(Sigma) as described for cytokine analysis here above and primer pairs specific for the lineages 
Bacteroidetes, Enterobacteriaceae, Lachnospiraceae, clostridial cluster IV and Lactobacillaceae 
(table1) The forward primer specific for the Ruminococcaceae species was designed by 
choosing a stretch of 16S RNA gene sequence that was distinctive from the corresponding 
sequences of other Ruminococcaceae of the clostridial cluster IV. Cycling conditions were 40 
cycles at 95°C for 15 s, 66°C for 20 s and 72°C for 20 s after an initial denaturation at 95°C for 
10 min. Quantification values were calculated by the 2-Ct method relative to total bacteria 16S 
rDNA amplification. 
Germfree colonization - Cecal contents (100 mg) of Wt and St3gal4-null donor mice were 
collected under anaerobic conditions and diluted in 10 ml of anaerobic mineral solution 
containing 5 g/l NaCl, 2 g/l glucose, and 0.3 g/l cysteine-HCl (de Sablet et al., 2009). Three to 
four week old C57Bl/6 germfree males (Institute of Laboratory Animal Science, University of 
Zürich, Switzerland) were colonized with 200 µl of 1:100-diluted cecal microbiota by gavage and 
kept in isolators for 4 weeks. 
Statistics - Results were expressed as mean ± SEM. Difference between groups was analyzed 
using one-way ANOVA with Bonferroni’s Multiple Comparison Post-test. Significance was 
accepted for p<0.05. 
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Figure legends 
Figure 1. Sialyltransferase gene expression in mouse mammary gland. The relative mRNA 
levels of the six α2,3 sialyltransferases St3gal1 to St3gal6 and of the two α2,6 sialyltransferases 
St6gal1 and St6gal2 was measured in virgin mice (mRNA levels set to 1) at 1 week postpartum, 
2 weeks postpartum and 3 days post weaning (N = 3). 
 
Figure 2. Sialyllactose concentration in mouse milk during lactation. (A) Sialyllactose in 
milk from Wt, St3gal1-, St3gal4-, St6gal1-null mice isolated at day 2 postpartum. α2,3- (3SL, 
solid line) and α2,6- (6SL, dashed line) linked sialyllactose were measured in Wt milk (B) and in 
St3gal4-null milk (C) throughout lactation. Amounts are given in g per 100 g dried milk. Values 
are measured by mean ± SEM (N = 3). 
 
Figure 3. DSS-induced colitis. (A) Body weight was determined daily in Wt mice (● solid line), 
cross-fostered Wt mice (▲ dashed line), St3gal4-null mice (● solid line) and cross-fostered 
St3gal4-null mice (▲ dashed line). (B) Reduction of colon length. Values are given as 
percentage of untreated control mice; C, control mice, DSS, DSS-treated mice, CF/DSS, cross-
fostered DSS-treated mice. (C) Intestinal permeability as measured by FITC-dextran levels in 
serum from controls and colitogenic mice on day 5 of DSS induced colitis (N = 4-8). (D-F) 
Cytokine gene expression at day 5 of DSS treatment. Measurements were performed using 2 - 
∆∆ct method with GAPDH as housekeeping gene (N = 8). Data are represented by mean ± SEM, * 
p<0.05. 
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Figure 4. Hematopoietic cell infiltration and bone marrow chimera of Wt and St3gal4-null 
mice. Colonic cells were isolated and stained with anti-CD45 APC-Cy7 antibody and measured 
by FACS. Mice were analyzed on day 0, 5 and 7 of DSS treatment. (A) Representative dot plots 
of Wt, cross-fostered Wt mice (Wt CF), St3gal4-null and cross-fostered St3gal4-null mice 
(St3gal4-null CF). (B) Quantitation of CD45+ cells in colon infiltrates (N = 4-8). (C) Body weight 
of Wt mice transplanted with St3gal4-null bone marrow cells (▲, N = 10) and St3gal4-null mice 
transplanted Wt bone marrow cells (●, N = 11) during DSS treatment. Error bars are expressed 
as mean ± SEM, * p<0.05. 
 
Figure 5. Microbiota analysis in the mouse gastrointestinal tract. TTGE profiles of 16S 
rDNA amplification products from cecum of 6 week-old Wt and St3gal4-null mice fed with either 
Wt or St3gal4-null milk (A) and after DSS induced colitis (B). The marker (M) shows 
amplification products from the species Lactobacillus plantarum, Lactococcus lactis, 
Corynebacterium variabile, Brevibacterium linens, Arthrobacter protophormiae from top to 
bottom. Arrows (►) mark the position corresponding to the Ruminococcaceae bands (N = 6). 
 
Figure 6. Quantitative analysis of gastrointestinal microbiota. The microbiota composition of 
Wt, St3gal4-null and respective cross-fostered (CF) mice was determined by real-time PCR in 
(A) native microbiota, and (B) microbiota on day 7 of DSS treatment. (C) Real-time PCR of 
Ruminococcaceae species in Wt, St3gal4-null and CF mice in controls and after 7 days of DSS 
induced colitis. Values are shown as relative amount to total bacteria 16S rDNA measured by 
the 2-Ct method. Error bars are expressed as mean ± SEM (N = 4-6), * p<0.05. 
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Figure 7. Colitis in reconstituted germfree mice.  (A) TTGE profiles of 16S rDNA 
amplification products from feces of mice colonized with Wt or St3gal4-null microbiota at two 
weeks post colonization (N = 6). (B) Body weight change in DSS-induced colitis of reconstituted 
germfree mice colonized with Wt (▼) or St3gal4-null (♦) microbiota (N = 9-11). The difference in 
body weights measured at day 7 was significant (p<0.05) 
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Table I: List of primers for the amplification of sialyltransferase genes and bacterial 
populations 
Names Primers Sequences 3’-5’ References 
St3Gal1 mQ_S3G-I Fwd CACCTGCAGACACTGCATCAG (present study) 
 mQ_S3G-I Rev TCAGAGCGTTGTGGACTGTCA  
St3Gal2 mQ_S3G-II Fwd CCGAACAACTCACCATTTCATG (present study) 
 mQ_S3G-II Rev GCGCTGGCAATCCACATTA  
St3Gal3 mQ_S3G-III Fwd GGCTACGCTTCAGCCATGA (present study) 
 mQ_S3G-III Rev CCCAAAAGGTGGCACAAACT  
St3Gal4 mQ_S3G-IV Fwd TCCAGGGTGAGGCAGAGAGA (present study) 
 mQ_S3G-IV Rev GTCCCAAAGGGCAGCTCATA  
St3Gal5 mQ_S3G-V Fwd GCAGCCTCCACAGGGACTT (present study) 
 mQ_S3G-V Rev AATAGGACGAAGAGGTGCACAGA  
St3Gal6 mQ_S3G-VI Fwd CCCAAGGATCAGAAACCCAAA (present study) 
 mQ_S3G-VI Rev CATGGTGGCATTCCCGTAGT  
St6Gal1 mQ_S6G-I Fwd GCGCAAGACAGATGTGTGCTA (present study) 
 mQ_S6G-I Rev TCTGTTCCCTCATTGAGATGCTT  
St6Gal2 mQ_S6G-II Fwd CTATGACAGCGACATGCTGTCA (present study) 
 mQ_S6G-II Rev CACCATGCTTGTTGAAGGACAT  
Total Bacteria 515F GTGCCAGCMGCCGCGGTAA (Frank et al., 2007) 
 805R GACTACCAGGGTATCTAAT  
Bacteroidetes Bac303R CCAATGTGGGGGACCTTC (Frank et al., 2007) 
 Bac32F AACGCTAGCTACAGGCTT  
Enterobacteriaceae Eco1457F CATTGACGTTACCCGCAGAAGAAGC (Bartosch et al., 2004) 
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 Eco1652R CTCTACGAGACTCAAGCTTGC  
Lachnospiraceae Ccocc1F CGGTACCTGACTAAGAAGC (Rinttilä et al., 2004) 
 Ccocc1R AGTTTYATTCTTGCGAACG  
Clostridial cluster IV Clep866mF TTAACACAATAAGTWATCCACCTGG (Ramirez-Farias et al., 2009) 
 Clept1240mR ACCTTCCTCCGTTTTGTCAAC  
Lactobacillaceae F_Lacto 05 AGCAGTAGGGAATCTTCC (Furet et al., 2009) 
 AR_Lacto 04 CGCCACTGGTGTTCYTCCATATA  
Ruminococcaceae 
species Ruminococcaceae CTAGGTGAAGATACTGACGGTAACCTG (present study) 
  HDA-2 GTATTACCGCGGCTGCTGGCAC (Walter et al., 2000) 
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Figure 6
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